肺炎球菌和b型流感嗜血杆菌疫苗接种的延迟启动
本研究基于2016-2021年美国国家儿童免疫调查的99,652名儿童数据,量化了7月龄及以上才启动肺炎球菌(PCV)或b型流感嗜血杆菌(Hib)疫苗系列的儿童比例,并评估其按CDC补种指南完成系列接种的情况。结果显示约2.5%和2.3%的儿童分别延迟启动PCV和Hib系列,其中多数在6周至7月龄间未接种其他推荐疫苗,但大部分延迟启动者最终按补种指南完成了系列接种。
要点
- 2.5%和2.3%的美国儿童分别在7月龄及以上才启动PCV和Hib疫苗系列。
- 延迟启动PCV和Hib系列的儿童中,分别有34.9%和26.3%在6周至7月龄间接种过其他疫苗。
- 约77.4%的延迟启动PCV儿童和87.5%的延迟启动Hib儿童按补种指南完成了系列接种。
核心结论
- 一部分美国儿童在7月龄及以上才启动PCV或Hib疫苗系列,且多数在6周至7月龄间未接种其他推荐疫苗,这凸显了需要基于证据的干预措施来支持早期获得初级保健。
研究设计与样本
- 横断面研究,分析2016-2021年美国国家儿童免疫调查中99,652名儿童的疫苗记录。
主要发现
- 在99,652名儿童中,2.5%(95%CI:2.2-2.7%)和2.3%(95%CI:2.1-2.5%)的美国儿童分别延迟启动PCV和Hib系列。
- 延迟启动PCV和Hib系列的中位年龄分别为384天和407天。
- 34.9%(95%CI:29.9-39.9%)的延迟PCV启动者和26.3%(95%CI:21.2-31.4%)的延迟Hib启动者在6周至<7月龄期间接种了其他疫苗。
- 延迟启动PCV的比例从2016年的2.9%(95%CI:2.4-3.4%)降至2021年的1.7%(95%CI:1.3-2.1%)。
- 约77.4%(95%CI:69.0-83.9%)的延迟PCV启动者(常规4剂系列)和87.5%(95%CI:76.3-93.3%)的延迟Hib启动者(常规4剂系列)按补种指南完成了系列接种。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: For children who initiate a vaccine series late, the Centers for Disease Control and Prevention (CDC) provides a catch-up schedule to guide providers in achieving full vaccination. Typically, the routine and catch-up schedules recommend the same number of doses for series completion. However, children starting pneumococcal (PCV) or Haemophilus influenzae type b (Hib) vaccination at or after 7 months often require fewer doses than earlier initiators. We aimed to quantify late PCV and Hib series initiators and determine series completion within CDC catch-up guidelines. METHODS: This cross-sectional study analyzed vaccine records from the 2016-2021 National Immunization Survey-Child. We quantified the prevalence of and identified characteristics of children who initiated the PCV or Hib series at or after age 7 months (215 days). We evaluated late initiators' series completion based on age of series initiation and when subsequent doses were received. RESULTS: Of 99,652 children, 2.5 % (95 % CI: 2.2-2.7 %) and 2.3 % (95 % CI: 2.1-2.5 %) of U.S. children initiated PCV or Hib series late, respectively. The median age of late series initiation was 384 days for PCV and 407 days for Hib. Overall, 34.9 % (95 % CI: 29.9-39.9 %) of late PCV initiators, and 26.3 % (95 % CI: 21.2-31.4 %) of late Hib initiators, received other vaccines from age 6 weeks to <7 months. Late PCV initiation decreased from 2.9 % (95 % CI: 2.4-3.4 %) in 2016 to 1.7 % (95 % CI: 1.3-2.1 %) in 2021. About 77.4 % (95 % CI: 69.0-83.9 %) of late PCV (routine 4-dose series) and 87.5 % (95 % CI: 76.3-93.3 %) of late Hib (routine 4-dose series) initiators completed the series per catch-up guidelines. CONCLUSIONS: A subset of U.S. children initiated the PCV or Hib series at or after 7 months, and most had not received other recommended vaccines between 6 weeks and 7 months-underscoring the need for evidence-based interventions that support early access to primary care.
引用
- Albers AN, Fox ER, Michels SY, et al. Late initiation of pneumococcal and Haemophilus influenzae type b vaccinations. Vaccine. 2025. PMID: 40829385. doi:10.1016/j.vaccine.2025.127611
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。